Please Wait
Applying Filters...
menu
    • menu
    Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2025: J&J’s US$ 14.6 bn Intra-Cellular buyout kicks off deal frenzy; Ozempic clinches FDA nod for CKD

    Stock Recap
    #PipelineProspector

    Menu

    Sodium Stearyl Fumarate Excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    Product-page Product Main Page
    price-trend Ask Us

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    24/02/2025 Gangwal Healthcare
    India
    		 GANGWAL HEALTHCARE PRIVATE LTD 37309 SODIUM STEARYL FUMARATE USP EXCIPIENT 2022-07-12 Active IV N/A
    24/02/2025 Alcedo Pharmachem
    India
    		 ALCEDO PHARMACHEM PRIVATE LTD 36276 SODIUM STEARYL FUMARATE USP/NF 2021-10-04 Active IV N/A